In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Mounjaro (tirzepatide), a weight-loss injection, is now approved to treat moderate-to-severe obstructive sleep apnea in obese adults, offering a breakthrough option beyond CPAP therapy, despite ...

Among body composition measures, reductions in fat mass and lean mass due to maridebart cafraglutide treatment were 26.2% to 36.8% and 8.6% to 11.6%, respectively, among obese participants.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect may not ...